Arista Networks Stock Gets Bullish Upgrade — Analyst Sees Up to 40% Growth
Rosenblatt upgrades Arista Networks, citing strong AI demand and faster growth ahead.
Already have an account? Sign in.
Rosenblatt upgrades Arista Networks, citing strong AI demand and faster growth ahead.
Levi beats expectations, raises outlook as sales grow worldwide. Strong demand for jeans and DTC sales drives profits higher.
Insmed’s HS drug failed to beat placebo in a mid-stage trial, though it was safe. Development for this condition has been stopped.
Leerink sees major tailwind for Sutro Biopharma and initiates coverage with $38 price target.